Cargando…

Iron metabolism and chronic inflammation in IgA nephropathy

IgA nephropathy (IgAN), an immune-mediated chronic inflammatory kidney disease, is the most common primary glomerular disease in Asia, especially in China and Japan. The pathogenesis of IgAN is complex, and the main cause of IgAN is explained by the ‘multiple hit’ theory, which states that the depos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Zhang-yu, Li, Zhi, Chu, Ling, Liu, Yan, He, Jin-rong, Xin, Yu, Li, Ai-mei, Zhang, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	State-of-the-Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075521/ https://www.ncbi.nlm.nih.gov/pubmed/37013479 http://dx.doi.org/10.1080/0886022X.2023.2195012

Ejemplares similares

MicroRNAs in IgA nephropathy
por: Yao, Xingchen, et al.
Publicado: (2021)

Is hyperuricemia an independent prognostic factor for IgA nephropathy: a systematic review and meta-analysis of observational cohort studies
por: Zhang, Kang, et al.
Publicado: (2022)

Prognostic value of low-density lipoprotein cholesterol in IgA nephropathy and establishment of nomogram model
por: Tian, Zhang-Yu, et al.
Publicado: (2023)

Clinicopathologic comparisons of IgA nephropathy and IgA vasculitis nephropathy in children: a ten-year single-center experience
por: SU, QingXiao, et al.
Publicado: (2021)

Iron metabolism-related indicators as predictors of the incidence of acute kidney injury after cardiac surgery: a meta-analysis
por: Zhao, Limei, et al.
Publicado: (2023)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

IgA nephropathy with leucocytoclastic vasculitis
por: Wei, Lin-Yan, et al.
Publicado: (2018)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy
por: Zhai, Ya-Ling, et al.
Publicado: (2016)

Icariin ameliorates IgA nephropathy by inhibition of nuclear factor kappa b/Nlrp3 pathway
por: Zhang, Lei, et al.
Publicado: (2016)

Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies
por: Pantel, Austin R., et al.
Publicado: (2018)

Obesity and inflammation: the linking mechanism and the complications
por: Ellulu, Mohammed S., et al.
Publicado: (2016)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Contrast associated nephropathy after intravenous administration: what is the magnitude of the problem?
por: Rachoin, Jean-Sebastien, et al.
Publicado: (2021)

The Role of Complement in Microangiopathic Lesions of IgA Nephropathy
por: Li, Jingyi, et al.
Publicado: (2022)

Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy
por: Li, Huining, et al.
Publicado: (2017)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
por: He, Jia-Wei, et al.
Publicado: (2022)

Iron deficiency and cardiovascular disease
por: Savarese, Gianluigi, et al.
Publicado: (2022)

The Feasibility of Targeted Magnetic Iron Oxide Nanoagent for Noninvasive IgA Nephropathy Diagnosis
por: Wu, Yaoyao, et al.
Publicado: (2021)

The Emerging Role of Pathogenesis of IgA Nephropathy
por: Wu, Meng-Yu, et al.
Publicado: (2018)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

IgA nephropathy to proliferative glomerulonephritis with monoclonal IgAκ deposits: a pattern switch
por: Li, Jin-pu, et al.
Publicado: (2023)

The role of innate lymphoid cells in selected disease states – cancer formation, metabolic disorder and inflammation
por: Poniewierska-Baran, Agata, et al.
Publicado: (2019)

Gut-kidney axis in IgA nephropathy: Role on mesangial cell metabolism and inflammation
por: Luvizotto, Mateus Justi, et al.
Publicado: (2022)

IgG4-related disease in endocrine practice
por: Rzepecka, Agata, et al.
Publicado: (2017)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review
por: Sun, Qiang, et al.
Publicado: (2016)

Hypertension/prehypertension and its determinants in pediatric IgA nephropathy
por: Fu, Qing-Ying, et al.
Publicado: (2020)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
por: Chen, Pei, et al.
Publicado: (2018)

Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
por: Zan, Jincan, et al.
Publicado: (2022)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Highlights of Pharmacist Roles in Hematopoietic Cell Transplantation and Cellular Therapy
por: Shi, Ho Ying, et al.
Publicado: (2021)

IgA Nephropathy: A Chinese Perspective
por: Zhang, Zhao, et al.
Publicado: (2021)

Corrigendum: Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?
por: He, Jia-Wei, et al.
Publicado: (2023)

Zonulin, as a marker of intestinal permeability, is elevated in IgA nephropathy and IgA vasculitis with nephritis
por: Li, Qianqian, et al.
Publicado: (2022)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Iron and Heart Failure: Diagnosis, Therapies, and Future Directions
por: Ghafourian, Kambiz, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_phten7b6e48f8rbmpclrf2q3bv